Prostate Cancer

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer. February 6, 2023

An analysis of PSMA-PET/CT-positive lymph node distribution and their coverage by different elective nodal radiation volumes in postoperative prostate cancer patients. February 6, 2023

The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer. February 6, 2023

Neighborhood Deprivation and Rurality Associated with Patient-Reported Outcomes and Survival in Men with Prostate Cancer in NRG RTOG 0415. February 6, 2023

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. February 6, 2023

Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy. February 6, 2023

Impact of hTERT peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring. February 3, 2023

Multimodality Therapies for Localized Prostate Cancer. February 3, 2023

Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic review. February 3, 2023

High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data. February 3, 2023

A nomogram model for determining optimal patients for local therapy in metastatic prostate cancer: a SEER database-based study. February 3, 2023

Association between ABO blood group and unfavorable prostate cancer features after radical prostatectomy: Retrospective study of 1149 patients. February 3, 2023

18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer. February 3, 2023

Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope? February 2, 2023

Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries. February 2, 2023

Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy. February 2, 2023

Mask R-CNN assisted 2.5D object detection pipeline of 68Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging. February 2, 2023

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells. February 2, 2023

Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States. February 1, 2023

Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate. February 1, 2023

Page 1 of 1277

email news signup